Andrew Lowy
Surgery Residency · University of California (San Diego) Medical Center
Credentials: · · ·
History
- 1988–1989
NY Hospital Cornell University
Research
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Cancer Cell · 2003 · 2,075 citations
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2021 · 1,081 citations
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2017 · 795 citations
33 papers
29 papers
25 papers
17 papers
15 papers
12 papers · 2 as a fellow
- EC
11 papers
11 papers
Grants
- 2026–2031
Defining the Role of MICAL2 in KRAS Mediated Pancreatic Duct Neoplasia
National Cancer Institute · R01
Contact PI · $643K · University of California, San Diego
- 2026–2031
Targeted Degradation of Glycoimmune Checkpoints Siglec-7 and -9 for Cancer Immunotherapy
National Cancer Institute · R01
PI · $748.4K · Scripps Research Institute, the
- 2023–2028
2/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership
National Cancer Institute · U54
Project lead · $530K · University of California, San Diego
- 2022–2027
Regulation of PDAC Metabolism and Immunity by Collagen and Its Cleavage Products
National Cancer Institute · U01
PI · $5.2M · Sanford Burnham Prebys Medical Discovery Institute
Clinical trials
- 2019–2023
Nivolumab + Cabiralizumab + Gemcitabine in Patients With Stage IV Pancreatic Cancer
Principal investigator · Completed · Phase 2
Hitendra Patel
- 2024–2028
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
Study chair · Recruiting · Phase 1
University of California, San Diego
- 2025–2027
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
- 2019–2024
Sub-investigator · Recruiting · Phase 3
Surgimab